{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:39:05Z","timestamp":1757540345094,"version":"3.40.5"},"reference-count":15,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. J. Neurol. Sci."],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title><jats:p>The signs and symptoms of Lyme neuroborreliosis can overlap with non-infectious degenerative diseases such as multiple sclerosis (MS). In this study, we assessed a cohort of MS patients in Atlantic Canada for serological evidence of Lyme disease (LD). No positive serology was identified using the recommended two-tiered algorithm.<\/jats:p>","DOI":"10.1017\/cjn.2020.129","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T08:06:29Z","timestamp":1593417989000},"page":"842-844","source":"Crossref","is-referenced-by-count":5,"title":["Low Seroprevalence of Lyme Disease Among Multiple Sclerosis Patients in New Brunswick"],"prefix":"10.1017","volume":"47","author":[{"given":"Gregg","family":"MacLean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Robbin","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd F.","family":"Hatchette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7692-7150","authenticated-orcid":false,"given":"Duncan","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"S0317167120001298_ref12","first-page":"253","article-title":"The presence of anti-Borrelia burgdorferi antibodies in a group of multiple sclerosis patients in eastern Sicily. Preliminary data","volume":"15","author":"di Bella","year":"1993","journal-title":"Acta Neurol (Napoli)."},{"key":"S0317167120001298_ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171731"},{"key":"S0317167120001298_ref11","first-page":"141","article-title":"Lyme borreliosis and multiple sclerosis: any connection? A seroepidemic study","volume":"7","author":"Chmielewska-Badora","year":"2000","journal-title":"Ann Agric Environ Med."},{"key":"S0317167120001298_ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.121"},{"key":"S0317167120001298_ref7","doi-asserted-by":"publisher","DOI":"10.1086\/508667"},{"key":"S0317167120001298_ref4","unstructured":"4. Public Health Agency of Canada. Surveillance of Lyme disease, 2019. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/lyme-disease\/surveillance-lyme-disease.html (accessed Sept 9, 2019)"},{"key":"S0317167120001298_ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-018-0646-x"},{"key":"S0317167120001298_ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.6.760"},{"key":"S0317167120001298_ref2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2531081103"},{"key":"S0317167120001298_ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2010.01411.x"},{"key":"S0317167120001298_ref10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.51.9.1215"},{"key":"S0317167120001298_ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168613"},{"key":"S0317167120001298_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"S0317167120001298_ref5","first-page":"3","article-title":"Multiple Sclerosis: Prevalence and impact","volume":"29","author":"Gilmour","year":"2018","journal-title":"Health Rep Stat Canada."},{"key":"S0317167120001298_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.08.025"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167120001298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T10:56:40Z","timestamp":1605610600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167120001298\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0317167120001298"],"URL":"https:\/\/doi.org\/10.1017\/cjn.2020.129","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"type":"print","value":"0317-1671"},{"type":"electronic","value":"2057-0155"}],"subject":[],"published":{"date-parts":[[2020,6,29]]}}}